Adastra Labs Holdings Ltd. is a Langley, BC-based cannabis company with a co-located Health Canada licensed standard processing facility and analytical testing laboratory. Adastra currently produces cannabis extracts through Supercritical CO2, cryo-ethanol extraction and wiped-film molecular distillation, and will have its hydrocarbon extraction lines installed and operational by years' end.
An acquisition in process for one of Canada's largest and prolific, legacy cannabis brands
Cannabis processing is one of the most profitable verticals in the cannabis space as the concentrates category and extract products are in high consumer demand
Recent equipment purchases allow for product SKU innovation and revenue expansion
This page contains statements that are “forward-looking information” and are based on numerous assumptions, and involve known and unknown risks, uncertainties and other factors, including risks that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE and Health Canada, economic, business, competitive, political and social uncertainties, failure to commission equipment, unexpected contamination of products, saturation of the market for the Company’s current and proposed future product offerings, failure of third parties to deliver on expected timelines, overestimation of competencies of third parties, termination of commercial engagements, termination of expected supply agreements and loss of key personnel. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com.